Related references
Note: Only part of the references are listed.Phase II study of the efficacy of abirateron acetate with dutasteride for castration-resistant prostate cancer.
Hideyasu Matsuyama et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research
Mohamed Elbadawy et al.
CANCERS (2020)
3D porous chitosan-chondroitin sulfate scaffolds promote epithelial to mesenchymal transition in prostate cancer cells
Kailei Xu et al.
BIOMATERIALS (2020)
In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening
Jessica Antunes et al.
ACTA BIOMATERIALIA (2019)
3D porous chitosan-alginate scaffold stiffness promotes differential responses in prostate cancer cell lines
Kailei Xu et al.
BIOMATERIALS (2019)
Treatment of Advanced Prostate Cancer-A Review of Current Therapies and Future Promise
Semini Sumanasuriya et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries
Takahiro Kuchimaru et al.
NATURE COMMUNICATIONS (2018)
Long-term liver-specific functions of hepatocytes in electrospun chitosan nanofiber scaffolds coated with fibronectin
Divya Rajendran et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2017)
Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond
Mary Nakazawa et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Epithelial-mesenchymal transition in prostate cancer: an overview
Micaela Montanari et al.
ONCOTARGET (2017)
Alteration of osteoblast arrangement via direct attack by cancer cells: New insights into bone metastasis
Yumi Kimura et al.
SCIENTIFIC REPORTS (2017)
Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy
Zhenfei Li et al.
NATURE (2016)
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
F. C. Hamdy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
Kristine M. Wadosky et al.
ONCOTARGET (2016)
Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice (vol 4, 64, 2016)
Monica Bartucci et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
3D Porous Chitosan-Alginate Scaffolds as an In Vitro Model for Evaluating Nanoparticle-Mediated Tumor Targeting and Gene Delivery to Prostate Cancer
Kui Wang et al.
BIOMACROMOLECULES (2015)
Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer
Masaki Shiota et al.
ENDOCRINE-RELATED CANCER (2015)
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Charles J. Ryan et al.
LANCET ONCOLOGY (2015)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Visceral Disease in Castration-resistant Prostate Cancer
Carmel J. Pezaro et al.
EUROPEAN UROLOGY (2014)
Prostate Cancer Cells Preferentially Home to Osteoblast-rich Areas in the Early Stages of Bone Metastasis: Evidence From In Vivo Models
Ning Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds
Ali Hussain et al.
BIOTECHNOLOGY AND BIOENGINEERING (2013)
Selection and adaptation during metastatic cancer progression
Christoph A. Klein
NATURE (2013)
The roles of TGFβ in the tumour microenvironment
Michael Pickup et al.
NATURE REVIEWS CANCER (2013)
TGF-beta in cancer and bone: Implications for treatment of bone metastases
Patricia Juarez et al.
BONE (2011)
Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
A. Shiirevnyamba et al.
BRITISH JOURNAL OF CANCER (2011)
Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Changmeng Cai et al.
CANCER RESEARCH (2011)
Cancer to bone: a fatal attraction
Katherine N. Weilbaecher et al.
NATURE REVIEWS CANCER (2011)
Effect of Dutasteride on the Risk of Prostate Cancer.
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer
Dorothea Weckermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Molecular biology of bone metastasis
Lauren A. Kingsley et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases
Theresa A. Guise et al.
CLINICAL CANCER RESEARCH (2006)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
